Concepedia
Statistics
Publications
10
Citations
392
H-Index
Active since
2008
Affiliations
University of Cambridge(Current)
The Christie NHS Foundation Trust
University of Manchester
Hutchison/MRC Research Centre
European Bioinformatics Institute
Richard Heywood is an author at University of Cambridge specializing in oncology, medicine, and glioblastoma.
Publications per year
2008–2022
Enhanced stability and activity of temozolomide in primary glioblastoma multiforme cells with cucurbit[n]uril
Eric A. Appel, Matthew Rowland, Xian Jun Loh et al. · Chemical Communications · 2012 · 85 citations
Pharmacy, Oncology, Pharmacology +17
Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma
Prachi Bhave, Tasnia Ahmed, Serigne Lo et al. · Journal for ImmunoTherapy of Cancer · 2022 · 65 citations · Full text
Life Sciences, Oncology, Pharmacotherapy +17
Contributions to Drug Resistance in Glioblastoma Derived from Malignant Cells in the Sub-Ependymal Zone
Sara Piccirillo, Inmaculada Spiteri, Andrea Sottoriva et al. · Cancer Research · 2014 · 62 citations · Full text
Medicine, Cancer Biology, Oncology +17
Checkpoint inhibitor-associated bullous cutaneous immune-related adverse events: a multicentre observational study
Anusuya Kawsar, Charlotte Edwards, Pooja Patel et al. · British Journal of Dermatology · 2022 · 45 citations · Full text
Life Sciences, Dermatology, Immunology +17
The NG2 Proteoglycan Protects Oligodendrocyte Precursor Cells against Oxidative Stress via Interaction with OMI/HtrA2
Frank Maus, Dominik Sakry, Fabien Binamé et al. · PLoS ONE · 2015 · 30 citations · Full text
Life Sciences, Neuroscience, Oncology +17
1–5 of 10